ClinicalTrials.govpublic full text
Futibatinib and Pembrolizumab for Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer
advanced hepatocellular carcinoma, bclc stage a hepatocellular carcinoma, bclc stage b hepatocellular carcinoma, bclc stage c hepatocellular carcinoma, metastatic hepatocellular carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 879663
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.